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Abstract
Objective: To report a case of a lethal morphine overdose in a breastfed 
infant secondary to medication transfer into breast milk.  
Case Report: The mother of a 6 ½ week old breastfed infant contacted 
emergency services secondary to her child being unresponsive.  The infant was 
pronounced dead on arrival of medical personnel to the scene, and the mother 
reported taking numerous medications including morphine sulfate. Autopsy 
of the infant revealed lethal levels of morphine in samples of her tissue.  The 
mother was charged with homicide, which is the first case of homicide secondary 
to medication transfer into breast milk. 
Discussion:  Medication transfer into breast milk is dependent on many 
factors, including size and molecular weight, lipid solubility, protein binding, 
and pH.  Infant response to the presence of medications in breast milk is 
dependent upon age-related pharmacodynamic factors that change weekly in 
rapidly growing and maturing infants, specifically volume of distribution, growth 
patterns, organ maturation, and digestive abilities.  Infants also have a lower 
fat concentration, therefore exposure to fat-soluble drugs like morphine have 
enhanced blood-brain barrier penetration and ultimate accumulation following 
prolonged exposure.  
Conclusion: Enhanced awareness of medication exposure to infants via 
breast milk is vital to prevent morbidity and mortality.  An understanding of the 
mechanism of medication transport into breast milk, as well as differences in 
infant response to medications based on pharmacodynamics, are crucial in the 
medical management of a breastfeeding mother.  In order to minimize toxicity to 
the breastfeeding infant, utilizing the lowest effective dose for a minimal amount 
of time is the cornerstone recommendation.
Keywords: Pharmacodynamics; Lethal morphine; Paracellular; Breast milk
of Pediatrics (AAP) does consider morphine to be compatible with 
breastfeeding [2,3]. However, the AAP also states that an infant may 
have measurable blood concentrations of morphine following long-
term repeated exposure [4].
We report a case of a lethal morphine overdose in a breastfed 
infant whose mother had prescriptions for morphine sulfate, along 
with numerous other medications.  To our knowledge, this is the first 
case of a mother charged with homicide secondary to medication 
transfer via breast milk.
Case Report
Emergency services were contacted about a 6 ½ week-old infant 
girl who was reportedly unresponsive. The dispatcher instructed 
the mother on CPR. Emergency services arrived approximately 12 
minutes after 911 was called. The child was pronounced dead on 
arrival, and the coroner was requested at the scene. Interview with the 
coroner revealed that the mother went to bed breastfeeding the child 
around 11 pm the previous night. The father of the infant woke at 5 am 
the following morning to find the child cold and unresponsive with 
fixed pupils. The mother stated she last breastfed the child around 2 
am.  The mother also reported that a few days before, the child was 
Introduction
In recent years the use of opioid analgesics, including morphine, 
has increased among the general population. The CDC reported 
in 2013 that for every woman that dies of a prescription painkiller 
overdose, 30 go to the emergency department for painkiller abuse or 
misuse [1]. Women of childbearing age are the population most likely 
to abuse or misuse prescription analgesics [1]. Abuse of prescription 
painkillers by pregnant and lactating women can put infants at risk, 
including neonatal abstinence syndrome and potential overdose. 
Between 2000 and 2009 reports of neonatal abstinence syndrome 
grew almost 300% in the United States [1].
Unfortunately there have not been many studies done on the 
concentrations of drugs found in the plasma and their relative transfer 
into the breast milk of a lactating mother. While the pharmacokinetics 
of morphine are known, there are individual characteristics of the 
mother and infant that ultimately effect the total concentrations of 
drug. The concentration of morphine that is lethal to an infant has not 
been well documented and can differ significantly due to age, body 
weight, fat distribution, and renal and hepatic enzyme development. 
The mother’s metabolism of the drug is another factor that influences 
the amount transferred into breast milk. The American Academy 
Case Report
Morphine Overdose in a 6 ½ Week-Old Infant: A Case 
Report
Eagerton DH1*, Goodbar NH2, Dansby MC3, Abel 
SN4 and Bell WC5
1Department of Pharmaceutical and Administrative 
Sciences, Presbyterian College School of Pharmacy, USA
2Department of Pharmacy Practice, Presbyterian College 
School of Pharmacy, USA
3Walgreen’s Pharmacy, USA
4Department of Pharmacy, Madigan Army Medical 
Center, USA
5Forensic Services, South Carolina Law Enforcement 
Division, USA
*Corresponding author: Eagerton DH, Department 
of Pharmaceutical and Administrative Sciences, 
Presbyterian College School of Pharmacy, 307 N Broad 
St, Clinton, SC 29325, USA
Received: July 11, 2014; Accepted: October 13, 2014; 
Published: October 14, 2014
Austin J Pharmacol Ther 2(10): id1052 (2014)  - Page - 02
Eagerton DH Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
sleeping more than usual and was lethargic with a decreased appetite. 
Two days prior to the death, parents called the pediatrician regarding 
congestion and “cold” symptoms.  Since the child was not running a 
fever they did not visit the office but instead were instructed to use a 
chest rub and vaporizer. The mother also reported that she gave 0.8 
mL of 150 mg/5 mL acetaminophen to the child the night before.  She 
said she alternated the acetaminophen with ibuprofen, but the exact 
dosage of ibuprofen given, if any, was not documented.
During the interview with the coroner the mother was asked 
about medications she was currently taking, and she reported that 
she was currently prescribed levetiracetam, baclofen, amlodipine, 
desvenlafaxine, clonazepam and hydrocodone/ibuprofen.  The 
prescribed dosages, date of last fill, and tablets remaining in the 
bottles are listed in Table 1. Upon search of the residence, prescription 
bottles for milancipran, carisoprodol, gabapentin, ropinirole, 
morphine sulfate extended release, and caffeine tablets were found. 
Details of these medications can be found in Table 2. All prescription 
medications found in the residence were prescribed to the mother. 
The medication most pertinent to this case is the morphine sulfate 
extended release, which she did not admit to taking upon her 
interview with the coroner.  This medication was originally prescribed 
to her in 1998 after a serious car accident that left her with a diagnosis 
of chronic pain.  Further investigation revealed that the prescriber 
of the morphine was unaware that the patient was pregnant and 
subsequently breastfeeding an infant.  Alternatively, the obstetrician 
and pediatrician were unaware that the mother was taking morphine.
Within 24 hours of the death, an autopsy of the infant was 
performed and tissue samples including heart blood, liver, and 
brain were taken for toxicological analysis.  Tissue samples were 
prepared as homogenates prior to analysis.  Morphine was extracted 
from biological samples using solid phase extraction.  Extracts were 
derivatized and analyzed for free morphine using full scan, gas 
chromatography mass spectrometry. The toxicology findings are 
listed in Table 3.  The post-mortem examination revealed diffuse 
acute passive congestion with minor acute intra-alveolar hemorrhage 
bilaterally, diffuse multifocal subarachnoid congestion of the brain, 
and cerebral edema.  Based on the history, autopsy and toxicological 
findings, it was determined that the death was the result of respiratory 
insufficiency secondary to synergistic drug intoxication.
The mother was charged with homicide by child abuse, involuntary 
manslaughter and unlawful conduct towards a child. She was tried 
and convicted of all three charges and subsequently sentenced to 20 
years in prison, the maximum amount allowable by law for homicide 
by child abuse. This case has set precedence for future cases, as it was 
the first to ever prosecute a mother for killing her child by substances 
transferred through breast milk. 
Discussion
Due to the rise in analgesic use among women and the potential 
for infant harm, a discussion on medication transfer into breast milk 
and infant response to medications is warranted.  Milk formation is 
complex, however in order to understand the transportation of drugs 
into breast milk it is essential to have a basic understanding of how 
milk is produced. Breast physiology is markedly changed during 
pregnancy due to increases in estrogen and progesterone and in 
the post partum period by an elevation in prolactin [5-7]. With the 
increase in hormones, there is an increase in the size and number of 
alveolar units which are responsible for the production of milk [5,6]. 
The transfer of drug into breast milk can occur via passive diffusion, 
carrier mediated transport and paracellular pathway [6]. Immediately 
postpartum, drugs are able to diffuse into the alveolus through the 
paracellular pathway due to incomplete closure of junctions between 
the mammary alveolar cells [6]. After several days the junctions close 
and the paracellular pathway is impeded thereby facilitating passive 
diffusion and carrier-mediated transport more readily [6].
There are several factors that affect the transport of drug into the 
breast milk. These factors include size and molecular weight, lipid 
solubility, protein binding and acid base conditions [5,6]. (Figure 1) 
Medication Dose Prescribed Last Filled Quantity filled / Quantity remaining
Hydrocodone 7.5 mg – Ibuprofen 200 mg 1 PO TID 8 days prior 90 / 42
Clonazepam 2mg 1 PO TID 8 days prior 90 / 77
levetiracetam 500 mg 1 PO BID 9 months prior 60 / 41
levetiracetam 500 mg 1 PO BID 6 months prior 60 / 27
Baclofen 10 mg ½ to 1 PO TID 8 days prior 90 / 46
Amlodipine Besylate 5 mg 1 QD 3 days prior 30 / 21
Desvenlafaxine Unknown – no bottle found
Table 1: Medications Mother admitted to taking.
Abbreviations: PO: Orally; TID: Three Times Daily; BID: Twice Daily; QD: Every Day
Medication Dose Prescribed Last Filled Quantity filled / Quantity remaining
Ropirinole HCl 1mg 1PO QHS 8 days prior 90 / 75
Gabapentin 800 mg 1 PO BID 14 days prior 60 / 14
Milnacipran  50 mg 1 PO BID 5 months prior 60 / 55
Carisoprodol 350 mg 1-2 PO BID 1 month and 15 days prior 360 /59
Morphine Sulfate ER 30 mg 1 PO Q8hr PRN 23 days prior 90 / 12
Caffeine Tablets 200 mg N/A N/A 16 / 6
Table 2:  Additional Medications found at scene prescribed to Mother.
Abbreviations: PO: Orally; BID: Twice Daily; QHS: Every Day at Bedtime; Q8hr: Every 8 hours; PRN: as needed
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Molecules of lower weight will transfer more readily into the breast 
milk [5,6]. Human breast milk contains approximately 4% fat, which 
is significantly higher than blood fat concentration (<1%) [5,6]. Due 
to the heavier concentration of fat in the milk, lipid soluble drugs 
may diffuse and become trapped allowing for higher milk-to-plasma 
Ratios [5,6]. Protein binding has a two-fold mechanism. Drugs with 
high maternal protein binding will accumulate in the maternal plasma 
and are less likely to transfer into breast milk [5,6]. Alternatively 
drugs with low maternal protein binding may more readily diffuse 
into breast milk and bind to milk proteins thereby accumulating in 
the breast milk [5,6]. Human milk has a lower pH (7) than serum 
(7.35-7.45) [5,6]. Due to milk’s lower pH, ion trapping can occur with 
weak bases allowing for higher concentrations in breast milk [5,6].
Individual maternal pharmacodynamic factors can also play a 
large role in the concentration of drug available in the breast milk. 
Absorption, distribution, metabolism and elimination can vary from 
woman to woman depending on genetic, nutritional and health 
related factors. Pharmacodynamic factors in infants vary widely from 
week to week secondary to rapidly changing volume of distribution, 
growth patterns, organ maturation, and digestive abilities. Absorption 
in infants is generally slower than that of an adult [6]. Variables 
such as gastric pH and intestinal flora are responsible for changes 
in absorption [6]. Along with physical variables, the bioavailability 
of the drug administered will play a significant role in its absorption 
[7]. Body composition affects the distribution of drugs, and when 
comparing newborns, infants, and adults they all have vastly different 
fat compositions [6]. As aging occurs the percentage of fat in total 
body composition increases. Administration of a fat-soluble drug, 
such as morphine, to an individual with a lower fat concentration 
will enhance accumulation in the brain secondary to increased 
penetration of the blood-brain barrier [6,8]. This property could 
potentially lead to adverse CNS effects [6,8]. Hepatic enzymes such 
as UGT2B7,which are responsible for morphine metabolism, are not 
fully active until several months of age.  The glomerular filtration 
rate in full term newborns is approximately 25% of that in adults not 
reaching full potential until 3-5 months of age [6,9]. Due to decreases 
in hepatic metabolism and renal excretion, drugs such as morphine 
that form glucuronides are subject to longer half-lives in infants (3-14 
hours) than their adult counterparts (2-3 hours).  In this case only 
the free morphine was measured, therefore the contribution from the 
glucuronide metabolites is unknown. 
The therapeutic, toxic, and lethal ranges reported in Table 3 
represent a composite of ranges that have been reported in the 
literature. Although there is limited data concerning morphine 
exposure in neonates, Robieux et. al. report a case where a neonate 
(< 2 week) was exposed to morphine via breast milk. The neonate 
developed clinically significant symptoms with a level of 0.004 mg/L 
(4 ng/ml) morphine [2].  A 10 month old boy who died following an 
exposure to ethylmorphine had postmortem levels of 0.054 mg/L (54 
ng/ml) of ethylmorphine and 0.026 mg/L (26 ng/mL) morphine [10]. 
Additionally, there is a reported case where a 13 day-old neonate 
succumbed to a level of 0.07 mg/L (70 ng/mL) of morphine [11] 
and another report of an 8 year-old child who died as a result of an 
accidental oral ingestion of morphine sulfate with a resulting level of 
0.128 mg/L (128 ng/mL)[12]. The range associated with compounds 
such as morphine also reflects variances due to tolerance.  This range 
encompasses both the naïve user (lower end of the range) and the 
opioid tolerant user (upper end of the range).  Since the frequency 
and dose exposure of this infant to morphine is unknown, the level 
of tolerance cannot be determined.  However, the level of morphine 
in the case presented in this paper represents a level that is well above 
the levels that have been reported to cause death in adults, children, 
and other infants. 
One final concern in interpreting the levels of morphine is the 
phenomenon of post-mortem redistribution.  The heart/femoral 
blood concentration ratio for morphine has been reported to be an 
average of 1.2 to 2.2 [13].  Again, the level of morphine in this case 
is well above the levels that have been associated with death from 
morphine intoxication even when considering any redistribution, 
and analysis of brain and liver tissue confirm that the infant was 
exposed to a lethal amount of morphine.
Analyte: Levels: Results:
Acetaminophen
Therapeutic: 10-20 mg/L
Toxic: 150 mg/L
Lethal: > 160 mg/L
19 mg/L
Diphenhydramine
Therapeutic: 0.025-0.112mg/L
Toxic: 5 mg/L
Lethal: > 8 mg/L
0.03 mg/L
Chlorpheniramine Therapeutic: 0.01 - 0.017 mg/L
Lethal: 0.5 – 1.7 mg/L
0.06 mg/L
Methorphan Therapeutic: 0.15 - 0.4 mg/L
Lethal: > 3mg/L
0.03 mg/L
Methorphinan Therapeutic: 0.007-0.021 mg/L
Lethal: 0.8-2.7 mg/L
0.04 mg/L
Morphine Therapeutic: 0.1 – 0.3 mg/L
Lethal: 0.1 – 4 mg/L
0.52 mg/L
Clonazepam Therapeutic: 0.007 – 0.028 mg/L
Toxic: 0.46 mg/L
0.01 mg/L
Table 3:  Toxicology report from blood, brain tissue and liver tissue samples of 
the infant.
Blood:
Analyte: Result:
Morphine 0.64 mg/Kg
Brain:
Analyte: Result:
Morphine 0.56 mg/Kg
Lethal: 0.4 – 18 mg/Kg (average 3.0 mg/Kg)
Liver:
 
Maternal Drug 
Dose
•Frequency, total daily dosage and route of administration
Maternal Blood 
Concentration
•Factors affecting maternal serum drug concentration include absorption, distribution, 
metabolism and elimination of the drug
Maternal Milk 
Concentration
•Molecular weight, acid base conditions, protein binding and fat solubility determine the 
milk-to-plasma ratio.
Infant blood 
concentration
•Initial concentration is determined by amount of mother's milk ingested by the infant
•Final blood concentration determined by absorption, distribution, metabolism and 
elimination by the infant. 
Infant 
Effects
•Infants health and pharmacodynamic factors
Figure 1: Drug Concentration Cascade from Mother to Infant.
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Conclusion
This was an unfortunate case of morphine toxicity that was 
exacerbated by the combination of other drugs with synergistic activity 
leading to CNS and respiratory depression. The bioavailability of 
morphine is 17-33% following oral administration. This may explain 
why few cases of toxicity have been reported. However in conjunction 
with decreased hepatic metabolism and renal excretion in the infant, 
morphine concentration could have accumulated. With the infant’s 
body composition and repeated exposure, CNS effects were markedly 
increased due to the diffusion across the blood-brain barrier. 
Additionally, the dose of morphine that this infant received likely 
represents a much larger dose than what is usually seen in infants 
who are breastfeeding from mothers prescribed opioids post-partum. 
In this case, the chronic misuse of extended release morphine by the 
breastfeeding mother led to the toxicity seen in this infant.
When considering analgesic treatment for a lactating mother 
one must weigh all potential risks to the infant. As always, using the 
lowest effective dose for a minimal amount of time is recommended 
with any medication in order to minimize the risk of toxicity to the 
infant. 
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